Cargando…

Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India

BACKGROUND AND OBJECTIVES: Seroprevalence estimation of COVID-19 is quite necessary for controlling the transmission of SARS-CoV-2 infection. Seroprevalence rate in recovered COVID-19 patients help us to identify individual with anti-SARS-CoV-2 antibodies and its protective nature. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, R., Mallya, M.V., Amoncar, S., Palyekar, S., Adsul, H.P., Kumar, R., Chawla, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295051/ https://www.ncbi.nlm.nih.gov/pubmed/34302953 http://dx.doi.org/10.1016/j.tracli.2021.07.004

Ejemplares similares

Whole blood donor deferral analysis at a center in Western India
por: Agnihotri, Naveen
Publicado: (2010)

Donor deferral due to anemia: A tertiary care center-based study
por: Bahadur, Shalini, et al.
Publicado: (2011)

Analysis of blood donor deferral pattern: Scenario in a Tertiary Health Care Hospital in India
por: Mangwana, Sadhana
Publicado: (2013)

Covid 19 vaccination: Latest guidelines on blood donor deferral in India
por: Bhasker, B.
Publicado: (2021)

Plateletpheresis donor deferral pattern: A retrospective 4-year data analysis at tertiary care center in India
por: Yadav, Brijesh Kumar, et al.
Publicado: (2022)

Blood donor deferrals: Can this be reduced?
por: Jashnani, Kusum D., et al.
Publicado: (2011)

Blood donor deferral periods after COVID-19 vaccination
por: Gupta, Abhaykumar Malind, et al.
Publicado: (2021)

Analysis of reasons of blood donor deferral at a tertiary care institute in India and its reflections on community health status
por: Malhotra, Sheetal, et al.
Publicado: (2023)

Profile of deferral of blood donors in regional blood transfusion center in North India
por: Sharma, Tanya, et al.
Publicado: (2013)

Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria
por: Okoroiwu, Henshaw Uchechi, et al.
Publicado: (2019)

Questionnaire-Related Deferrals in Regular Blood Donors in Norway
por: Reikvam, Håkon, et al.
Publicado: (2012)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Repeat donation and deferral rates in US source plasma donors: Exploratory analysis from the IMPACT trial
por: Hartmann, Jan, et al.
Publicado: (2021)

Blood donor selection and deferral pattern as an important tool for blood safety in a tertiary care hospital
por: Shrivastava, Manisha, et al.
Publicado: (2016)

A REVIEW OF PREDONATION BLOOD DONOR DEFERRALS IN A UNIVERSITY HOSPITAL
por: Bashawri, Layla A.M.
Publicado: (2005)

Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons
por: Al Shaer, Laila, et al.
Publicado: (2017)

Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran
por: Rafiee, Mohammad Hessam, et al.
Publicado: (2021)

An Original Approach to Evaluating the Quality of Blood Donor Selection: Checking Donor Questionnaires and Analyzing Donor Deferral Rate
por: Gillet, Philippe, et al.
Publicado: (2018)

Hepatitis E seroprevalence among blood donors: A pilot study from Western India
por: Gajjar, Maitrey D., et al.
Publicado: (2014)

Pre-donation deferral of blood donors in South Indian set-up: An analysis
por: Sundar, P., et al.
Publicado: (2010)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Blood Donor Deferrals for Malaria in Iran: A Five-Year Retrospective Study
por: MARDANI, Ahmad, et al.
Publicado: (2019)

COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period
por: Bansal, N., et al.
Publicado: (2021)

Assessment of noncompliance in self-disclosure of deferrable risk behaviors among blood donors
por: Venkatachalam, Bala Vignesh, et al.
Publicado: (2022)

Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
por: Andersen, Kylie J., et al.
Publicado: (2020)

Analysis of efforts to maintain safe donor in main donor pool after completion of temporary deferral period
por: Shah, Ripal, et al.
Publicado: (2013)

Donor notification of permanent deferral: a qualitative study on the perceptions and practices of notifier and blood donor in Mexico
por: Serrano-Delgado, V Moisés, et al.
Publicado: (2022)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Demographical Pattern of Blood Donors and Pre-Donation Deferral Causes in Dhahran, Saudi Arabia
por: Elsafi, Salah H
Publicado: (2020)

Frequency and Causes of Deferral among Blood Donors Presenting to Combined Military Hospital Multan
por: Iqbal, Hamid, et al.
Publicado: (2020)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania
por: Valerian, Donath Mkenda, et al.
Publicado: (2018)

Insight into donor deferral pattern based on peripheral blood counts: An experience from South Pakistan
por: Sultan, Sadia, et al.
Publicado: (2017)

Blood Donor Deferral Analysis in Relation to the Screening Process: A Single-Center Study from Southern India with Emphasis on High Hemoglobin Prevalence
por: Kandasamy, Dhivya, et al.
Publicado: (2020)

The Convalescent Plasma Craze! Where Does India Stand?
por: Priyadarsini, Arcot J., et al.
Publicado: (2021)

CHALLENGES IN THE PRODUCTION OF COVID-19 CONVALESCENT PLASMA – ANALYSIS OF DONOR RECRUITMENT
por: Sekiya, E.J., et al.
Publicado: (2020)

Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
por: Sekiya, Eliseo Joji, et al.
Publicado: (2021)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
por: Bonetti, Tatiana Carvalho de Souza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q9trr8apehc300mild9r5jkstu